Alison Moskowitz presented results of a Phase 1 study of combination duvelisib plus ruxolitinib in relapsed/refractory (R/R) peripheral T-cell lymphoma or cutaneous T-cell lymphoma Results ...
As insurgents swept across Syria in just 10 days to bring an end to the Assad family's 50-year rule, they broke into prisons and security facilities to free political prisoners and many of the tens of ...